Kanname hoolt inimeste tervise eest igas maailma nurgas
Choose a category or subcategory
B. Braun Grupi uudised
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.
B. Braun Receives FDA Clearance for SpaceStation MRI
Allows Space® Infusion Pumps to Continuously Deliver Medications Within the MRI Suite